Showing 12,381 - 12,400 results of 46,038 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (mean decrease)) ))', query time: 1.11s Refine Results
  1. 12381
  2. 12382

    The pulmonary hemodynamics and the fluctuation in the serum antibody levels against EXD2 and PHAX peptides in patients with CTEPH before and one year after pulmonary endarterectomy... by Akira Naito (663843)

    Published 2019
    “…<p>The mean pulmonary artery pressure decreased from 45.5±10.9 to 25.3±7.4 mmHg and the pulmonary vascular resistance decreaseased from 732.0±287.4 to 322.1±157.2 dyne·sec·cm<sup>-5</sup>. …”
  3. 12383

    Activation of deep SC neurons recapitulates delayed LER in <i>Setd5</i><sup><i>+/−</i></sup> animals. by Laura E. Burnett (18794525)

    Published 2024
    “…(<b>I</b>) Proportion of trials at different laser intensities that either show an increase (white), decrease (black), or no change (grey) in speed upon light activation for <i>Setd5</i><sup>+/+</sup> (top) and <i>Setd5</i><sup>+/<i>−</i></sup> (bottom). 0.01 mW mm<sup>−2</sup>: 35 trials, <i>p</i> = 0.649; 0.5 mW mm<sup>−2</sup>: 111 trials, <i>p</i> = 0.193; 5 mW mm<sup>−2</sup>: 50 trials, <i>p</i> < 0.001; 10 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001; 15 mW mm<sup>−2</sup>: 61 trials, <i>p</i> = 0.004; 20 mW mm<sup>−2</sup>: 49 trials, <i>p</i> < 0.001, X<sup>2</sup> test of independence. …”
  4. 12384
  5. 12385
  6. 12386

    Directed evolution of HIV-1 to utilize CD4<sup>low</sup> target cells. by David Beauparlant (3491435)

    Published 2017
    “…<b>(E)</b> Adaptation to CD4<sup>low</sup> target cells results in high resistance to CD4 inhibitor compared to wild type HIV-1 isolates. Comparison of IC50 of CD4-blocking DARPin 55.2 against 41 wild-type HIV-1 strains from different clades (black dots, see <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006255#ppat.1006255.s003" target="_blank">S3 Table</a> for details on virus panel and individual IC50 values) and the CD4<sup>low</sup> adaptation virus panel (colored dots, see legend) probed by Env pseudovirus infection on TZM-bl cells. …”
  7. 12387
  8. 12388
  9. 12389
  10. 12390
  11. 12391
  12. 12392

    Phenotypic characterization of <i>CsIVP</i>-RNAi transgenic plants. by Shuangshuang Yan (798064)

    Published 2020
    “…<p>(A) Plant morphology of WT and <i>CsIVP-</i>RNAi lines R5, R3, and R2. …”
  13. 12393
  14. 12394
  15. 12395
  16. 12396
  17. 12397
  18. 12398

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”
  19. 12399

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”
  20. 12400

    Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multip... by Obdulia Rabal (124515)

    Published 2021
    “…The corresponding epigenetic functional cellular responses are observed: histone-3 acetylation, DNA hypomethylation, and decreased histone-3 methylation at lysine-9. These chemical probes, multitarget epigenetic inhibitors, were validated against the multiple myeloma cell line MM1.S, demonstrating promising <i>in vitro</i> activity of <b>12a</b> (CM-444) with GI<sub>50</sub> of 32 nM, an adequate therapeutic window (>1 log unit), and a suitable pharmacokinetic profile. …”